Published in Orphanet J Rare Dis on October 09, 2013
Clinical evidence for orphan medicinal products-a cause for concern? Orphanet J Rare Dis (2013) 0.90
Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials (1996) 64.38
Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA (1996) 36.04
GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol (2011) 10.02
Evaluating non-randomised intervention studies. Health Technol Assess (2003) 9.69
Rare diseases, orphan drugs and their regulation: questions and misconceptions. Nat Rev Drug Discov (2010) 4.02
Scales to assess the quality of randomized controlled trials: a systematic review. Phys Ther (2007) 3.17
Clinical research for rare disease: opportunities, challenges, and solutions. Mol Genet Metab (2008) 2.91
Which clinical studies provide the best evidence? The best RCT still trumps the best observational study. BMJ (2000) 2.06
Reviews assessing the quality or the reporting of randomized controlled trials are increasing over time but raised questions about how quality is assessed. J Clin Epidemiol (2010) 1.21
Rare diseases and the assessment of intervention: what sorts of clinical trials can we use? J Inherit Metab Dis (2001) 1.14
Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency. Ther Clin Risk Manag (2011) 1.13
The role of evidence-based medicine and clinical trials in rare genetic disorders. Clin Genet (2008) 0.88
Evidence-based medicine and rare diseases. Adv Exp Med Biol (2010) 0.86
The diagnostic value of macroscopic haematuria for the diagnosis of urological cancer in general practice. Br J Gen Pract (2003) 3.15
Economic effects of clinical pharmacy interventions: a literature review. Am J Health Syst Pharm (2008) 3.11
A systematic review of appraisal tools for clinical practice guidelines: multiple similarities and one common deficit. Int J Qual Health Care (2005) 2.93
The onecut transcription factor HNF6 is required for normal development of the biliary tract. Development (2002) 2.89
Defining the palliative care patient: a systematic review. Palliat Med (2012) 2.59
Signs and symptoms for diagnosis of serious infections in children: a prospective study in primary care. Br J Gen Pract (2007) 2.48
Serious infections in children: an incidence study in family practice. BMC Fam Pract (2006) 2.29
Physical examination for lumbar radiculopathy due to disc herniation in patients with low-back pain. Cochrane Database Syst Rev (2010) 2.21
The association of common variants in PCSK1 with obesity: a HuGE review and meta-analysis. Am J Epidemiol (2014) 2.07
Endoscopic resection of ampullary lesions: a single-center 8-year retrospective cohort study of 91 patients with long-term follow-up. Surg Endosc (2013) 2.01
Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments? Orphanet J Rare Dis (2012) 2.00
A comparative study of European rare disease and orphan drug markets. Health Policy (2010) 1.73
Impact, regulation and health policy implications of physician migration in OECD countries. Hum Resour Health (2004) 1.72
Congenital veno-venous malformations of the liver: widely variable clinical presentations. J Gastroenterol Hepatol (2007) 1.68
European first aid guidelines. Resuscitation (2006) 1.63
Budget impact analysis of orphan drugs in Belgium: estimates from 2008 to 2013. J Med Econ (2010) 1.59
Generic and therapeutic substitution: ethics meets health economics. Int J Clin Pharm (2011) 1.45
Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis-associated liver disease. Hepatology (2011) 1.43
Increasing nurse staffing levels in Belgian cardiac surgery centres: a cost-effective patient safety intervention? J Adv Nurs (2010) 1.42
Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain (2008) 1.41
Signs and symptoms in diagnosing acute myocardial infarction and acute coronary syndrome: a diagnostic meta-analysis. Br J Gen Pract (2008) 1.33
Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Am J Surg Pathol (2006) 1.32
Generic medicine pricing in Europe: current issues and future perspective. J Med Econ (2008) 1.32
Tendering for outpatient prescription pharmaceuticals: what can be learned from current practices in Europe? Health Policy (2011) 1.29
Peripheral bile duct paucity and cholestasis in the liver of a patient with Alagille syndrome: further evidence supporting a lack of postnatal bile duct branching and elongation. Am J Surg Pathol (2005) 1.29
International trends in lifelong learning for pharmacists. Am J Pharm Educ (2007) 1.27
Implementing evidence-based medicine in general practice: a focus group based study. BMC Fam Pract (2005) 1.20
Prospective study comparing different indirect methods to measure portal pressure. J Vasc Interv Radiol (2011) 1.20
Effectiveness of electronic guideline-based implementation systems in ambulatory care settings - a systematic review. Implement Sci (2009) 1.18
A comparative analysis of remuneration models for pharmaceutical professional services. Health Policy (2009) 1.18
GPs' reasons for referral of patients with chest pain: a qualitative study. BMC Fam Pract (2009) 1.13
Spirituality in general practice: a qualitative evidence synthesis. Br J Gen Pract (2011) 1.13
Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions. Expert Rev Gastroenterol Hepatol (2011) 1.13
Drugs for rare diseases: influence of orphan designation status on price. Appl Health Econ Health Policy (2011) 1.10
The costs of breast cancer prior to and following diagnosis. Eur J Health Econ (2010) 1.09
Critical assessment of belgian reimbursement dossiers of orphan drugs. Pharmacoeconomics (2011) 1.09
Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries. Orphanet J Rare Dis (2013) 1.08
Personalizing health care: feasibility and future implications. BMC Med (2013) 1.07
Literature reviews should reveal the reviewers' rationale to opt for particular quality assessment criteria. Acad Med (2014) 1.07
Obstacles to implementing evidence-based dentistry: a focus group-based study. J Dent Educ (2008) 1.06
Why does the general practitioner refer patients with chest pain not-urgently to the specialist or urgently to the emergency department? Influence of the certainty of the initial diagnosis. Acta Cardiol (2009) 1.05
The attitude of Belgian social insurance physicians towards evidence-based practice and clinical practice guidelines. BMC Fam Pract (2009) 1.03
Interdisciplinary diabetes care teams operating on the interface between primary and specialty care are associated with improved outcomes of care: findings from the Leuven Diabetes Project. BMC Health Serv Res (2009) 1.02
How well do clinical prediction rules perform in identifying serious infections in acutely ill children across an international network of ambulatory care datasets? BMC Med (2013) 1.02
The correlation between portal myofibroblasts and development of intrahepatic bile ducts and arterial branches in human liver. Liver (2002) 1.01
Cost-effectiveness assessment of orphan drugs: a scientific and political conundrum. Appl Health Econ Health Policy (2013) 1.00
Neuroregulation of the neuroendocrine compartment of the liver. Anat Rec A Discov Mol Cell Evol Biol (2004) 0.99
Family physicians' perceptions and use of electronic clinical decision support during the first year of implementation. J Med Syst (2012) 0.99
Signs and symptoms in children with a serious infection: a qualitative study. BMC Fam Pract (2005) 0.99
Demand-side policies to encourage the use of generic medicines: an overview. Expert Rev Pharmacoecon Outcomes Res (2013) 0.97
The impact of reference-pricing systems in Europe: a literature review and case studies. Expert Rev Pharmacoecon Outcomes Res (2011) 0.97
Transcatheter arterial embolization for iatrogenic hemobilia is a safe and effective procedure: case series and review of the literature. Eur J Gastroenterol Hepatol (2012) 0.97
Does the market share of generic medicines influence the price level?: a European analysis. Pharmacoeconomics (2011) 0.96
Shining a light in the black box of orphan drug pricing. Orphanet J Rare Dis (2014) 0.96
Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs. Front Pharmacol (2013) 0.95
Orphan drugs for rare diseases: is it time to revisit their special market access status? Drugs (2012) 0.95
Results of diagnostic accuracy studies are not always validated. J Clin Epidemiol (2006) 0.95
Issues surrounding orphan disease and orphan drug policies in Europe. Appl Health Econ Health Policy (2010) 0.94
The attitude of Flemish occupational health physicians toward evidence-based occupational health and clinical practice guidelines. Int Arch Occup Environ Health (2009) 0.94
The impact of informing psychiatric patients about their medication: a systematic review. Pharm World Sci (2007) 0.94
Computerized general practice based networks yield comparable performance with sentinel data in monitoring epidemiological time-course of influenza-like illness and acute respiratory illness. BMC Fam Pract (2010) 0.93
Opposing expectations and suboptimal use of a local antibiotic hospital guideline: a qualitative study. J Antimicrob Chemother (2008) 0.93
Drug shortages in European countries: a trade-off between market attractiveness and cost containment? BMC Health Serv Res (2014) 0.93
Hepatitis B virus replication causes oxidative stress in HepAD38 liver cells. Mol Cell Biochem (2006) 0.92
Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease. J Cyst Fibros (2009) 0.92
EBMPracticeNet: A Bilingual National Electronic Point-Of-Care Project for Retrieval of Evidence-Based Clinical Guideline Information and Decision Support. JMIR Res Protoc (2013) 0.92
Medicinal use of potato-derived products: conclusions of a rapid versus full systematic review. Phytother Res (2010) 0.92
How can pharmacist remuneration systems in Europe contribute to generic medicine dispensing? Pharm Pract (Granada) (2012) 0.90
Clinical evidence for orphan medicinal products-a cause for concern? Orphanet J Rare Dis (2013) 0.90
Breast cancer resistance protein (BCRP/ABCG2) is expressed by progenitor cells/reactive ductules and hepatocytes and its expression pattern is influenced by disease etiology and species type: possible functional consequences. J Histochem Cytochem (2006) 0.89
Incident somatic comorbidity after psychosis: results from a retrospective cohort study based on Flemish general practice data. BMC Fam Pract (2011) 0.89
Both Ca2+ -dependent and -independent pathways are involved in rat hepatic stellate cell contraction and intrahepatic hyperresponsiveness to methoxamine. Am J Physiol Gastrointest Liver Physiol (2006) 0.89
Early versus late parenteral nutrition in ICU patients: cost analysis of the EPaNIC trial. Crit Care (2012) 0.89
Barriers to the uptake of biosimilars and possible solutions: a Belgian case study. Pharmacoeconomics (2014) 0.88
Online on-the-spot searching increases use of evidence during consultations in family practice. Patient Educ Couns (2007) 0.88
Economic evaluations of homeopathy: a review. Eur J Health Econ (2013) 0.87
European drug shortages: a call for action! Int J Pharm Pract (2013) 0.87
A cluster randomized trial to improve adherence to evidence-based guidelines on diabetes and reduce clinical inertia in primary care physicians in Belgium: study protocol [NTR 1369]. Implement Sci (2008) 0.87
Generic medicines: solutions for a sustainable drug market? Appl Health Econ Health Policy (2013) 0.87
Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders. J Comp Eff Res (2014) 0.87
Hepatobiliary malignancies in Wilson disease. Liver Int (2014) 0.87
Clinicopathological features of focal nodular hyperplasia-like nodules in 130 cirrhotic explant livers. Am J Gastroenterol (2006) 0.86
Reimbursement of orphan drugs in Belgium: what (else) matters? Orphanet J Rare Dis (2014) 0.86
Kiovig for primary immunodeficiency: reduced infusion and decreased costs per infusion. Int Immunopharmacol (2011) 0.86
Length of stay after reaching clinical stability drives hospital costs associated with adult community-acquired pneumonia. Scand J Infect Dis (2012) 0.86
Effectiveness of nonresuscitative first aid training in laypersons: a systematic review. Ann Emerg Med (2009) 0.86
Giant liver hemangioma: the role of female sex hormones and treatment. Eur J Gastroenterol Hepatol (2011) 0.85
Market access of cancer drugs in European countries: improving resource allocation. Target Oncol (2013) 0.85
HBx or HCV core gene expression in HepG2 human liver cells results in a survival benefit against oxidative stress with possible implications for HCC development. Chem Biol Interact (2007) 0.84
Evaluating and improving orphan drug regulations in Europe: a Delphi policy study. Health Policy (2012) 0.84
Barriers to evidence-based nursing: a focus group study. J Adv Nurs (2007) 0.84
Carbon monoxide produced by intrasinusoidally located haem-oxygenase-1 regulates the vascular tone in cirrhotic rat liver. Liver Int (2008) 0.84
Generic atypical antipsychotic drugs in Belgium: their influence and implications. J Comp Eff Res (2013) 0.84
Management dilemmas in pediatric nephrology: Cystinosis. Pediatr Nephrol (2015) 0.84